BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
11/15/2019 7:45:48 AM | Browse: 588 | Download: 1067
 |
Received |
|
2019-04-29 01:30 |
|
Peer-Review Started |
|
2019-05-09 03:04 |
|
To Make the First Decision |
|
2019-08-01 00:23 |
|
Return for Revision |
|
2019-08-01 06:48 |
|
Revised |
|
2019-08-10 13:43 |
|
Second Decision |
|
2019-09-10 10:19 |
 |
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Company Editor-in-Chief |
|
2019-09-10 23:15 |
|
Articles in Press |
|
2019-09-10 23:15 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
2019-09-26 01:34 |
|
Typeset the Manuscript |
|
2019-10-23 01:15 |
|
Publish the Manuscript Online |
|
2019-11-15 07:45 |
| ISSN |
1948-5204 (online) |
| Open Access |
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2019. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Oncology |
| Manuscript Type |
Observational Study |
| Article Title |
Clinical significance of MLH1/MSH2 for stage II and III sporadic colorectal cancer
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Shui-Ming Wang, Bin Jiang, You-Ping Deng, Shu-Liang Huang, Ming-Zhi Fang and Yu Wang |
| ORCID |
|
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| Medical Science and technology development Foundation，Nanjing Department of Health, |
No. YKK14140 |
| Medical Science and technology development Foundation，Nanjing Department of Health, |
No. ZKX15040 |
| Project of Administration of Traditional Chinese medicine of Jiangsu Province of China, |
No. LZ11101 |
|
| Corresponding Author |
Yu Wang, MD, PhD, Chief Doctor, oncology, entern, Nanjing hospital of Chinese medicine, Nanjing 210001, Jiangsu Province, China. christinewangyu@outlook.com |
| Key Words |
Colorectal cancer; Mismatch repair gene; MLH1; MSH2; Microsatellite instability; |
| Core Tip |
Mutation or methylation of mismatch repair gene leads to microsatellite instability (MSI), which is one of the most important mechanisms of colorectal cancer (CRC). The purpose of this study was to collect data of MLH1/MSH2 and MSI status in stage II-III CRC and to assess the predictive and prognostic value of this analysis. This is the first large study in China to evaluate the role of MLH1/MSH2 in CRC and its relationship with adjuvant chemotherapy. |
| Publish Date |
2019-11-15 07:45 |
| Citation |
Wang SM, Jiang B, Deng YP, Huang SL, Fang MZ, Wang Y. Clinical significance of MLH1/MSH2 for stage II and III sporadic colorectal cancer. World J Gastrointest Oncol 2019; 11(11): 1065-1080 |
| URL |
https://www.wjgnet.com/1948-5204/full/v11/i11/1065.htm |
| DOI |
https://dx.doi.org/10.4251/wjgo.v11.i11.1065 |
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
